Related Experiment Videos
Sexual dysfunction after treatment for gynaecologic and breast malignancies
1National Cancer Research Network Co-ordinating Centre, Leeds, UK. m.stead@cancermed.leeds.ac.uk
Current Opinion in Obstetrics & Gynecology
|January 25, 2003
Summary
Sexual dysfunction significantly impacts women with gynecologic and breast cancers, causing distress throughout treatment and follow-up. Improved communication and support are crucial for managing these sexual health challenges.
Area of Science:
- Oncology
- Sexual Health
- Patient Quality of Life
Background:
- Sexual dysfunction is a prevalent and distressing issue for patients diagnosed with gynecologic and breast cancers.
- Difficulties persist from initial diagnosis through long-term survivorship, affecting quality of life.
Purpose of the Study:
- To review current knowledge on sexual dysfunction in gynecologic and breast cancer patients.
- To highlight recent findings on treatment effects and communication challenges related to sexual health.
Main Methods:
- Literature review of recent publications.
- Synthesis of data on sexual dysfunction in cancer patients.
Main Results:
- Sexual dysfunction causes significant distress, particularly for younger women experiencing reproductive and relationship issues.
- Chemotherapy negatively impacts sexual function and quality of life; endocrine treatments may have age-dependent effects.
- Sexual self-schema is a key predictor; communication about sexual issues remains inadequate.
Conclusions:
- Understanding of treatment-related sexual dysfunction is growing, with identified predictive factors.
- Further research is needed to address diverse patient groups and effective interventions.
- Enhanced communication and support regarding sexual health are essential for cancer patients.